|
Re: Financial Future
|
3
|
Resverlogix Corp.
|
May 13, 2019 04:22PM
|
|
Re: Financial Future
|
5
|
Resverlogix Corp.
|
May 13, 2019 09:12PM
|
|
Re: Financial Future
|
|
Resverlogix Corp.
|
May 14, 2019 08:54AM
|
|
Re: Financial Future
|
1
|
Resverlogix Corp.
|
May 14, 2019 09:22AM
|
|
Re: Financial Statements and MD&A for the Period Ending November 30, 2018
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 30, 2019 01:37PM
|
|
Re: Financial Times article on UCSF Covid project about the 69 potential drugs
|
4
|
Resverlogix Corp.
|
May 01, 2020 10:24PM
|
|
Re: Financials
|
6
|
Zenith Epigenetics
|
Aug 09, 2019 11:05AM
|
|
Re: Financials
|
4
|
Zenith Epigenetics
|
Aug 09, 2019 12:17PM
|
|
Re: Financials are out
|
6
|
Resverlogix Corp.
|
Jul 30, 2018 10:50PM
|
|
Re: Financials are out
|
4
|
Resverlogix Corp.
|
Jul 31, 2018 09:14AM
|
|
Re: First Drug In History of Alzheimer's Slows It Down
|
5
|
Resverlogix Corp.
|
Jul 22, 2015 02:14PM
|
|
Re: First presentation of BETonMACE data at ESC 2019?
|
3
|
Resverlogix Corp.
|
Apr 30, 2019 01:46PM
|
|
Re: First xB3 platform technology licensing agreement with Prothena; USD$1M upfront+potential up to USD$33M in payments
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 29, 2018 08:40AM
|
|
Re: flacid
|
3
|
Resverlogix Corp.
|
Jun 09, 2017 10:59AM
|
|
Re: Flu vs. Covid19
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 08:30AM
|
|
Re: Flu vs. Covid19
|
2
|
Resverlogix Corp.
|
Apr 02, 2020 07:16AM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
9
|
Resverlogix Corp.
|
Jul 25, 2020 05:39PM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
3
|
Resverlogix Corp.
|
Jul 28, 2020 10:45AM
|
|
Re: For Scientists - Nature article/study on epigenetic changes after kidney injury
|
6
|
Resverlogix Corp.
|
Jul 09, 2020 11:57AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
5
|
Resverlogix Corp.
|
May 26, 2017 10:21AM
|
